L T Hamel

601 total citations
18 papers, 516 citations indexed

About

L T Hamel is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, L T Hamel has authored 18 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Physiology. Recurrent topics in L T Hamel's work include Phosphodiesterase function and regulation (11 papers), Nitric Oxide and Endothelin Effects (5 papers) and Enzyme function and inhibition (3 papers). L T Hamel is often cited by papers focused on Phosphodiesterase function and regulation (11 papers), Nitric Oxide and Endothelin Effects (5 papers) and Enzyme function and inhibition (3 papers). L T Hamel collaborates with scholars based in United States, Germany and Brazil. L T Hamel's co-authors include Paul J. Silver, Ross Bentley, Mark H. Perrone, Alex L. Harris, Dale B. Evans, Paul C. Canniff, Brendan O’Connor, Edward D. Pagani, Daniel Luttinger and George Y. Lesher and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

L T Hamel

18 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L T Hamel United States	14	268	178	169	72	69	18	516
Han-liang Zhou United States	8	296 1.1×	174 1.0×	75 0.4×	48 0.7×	36 0.5×	15	449
Eva Maria Becker Germany	7	335 1.3×	348 2.0×	327 1.9×	100 1.4×	37 0.5×	11	720
Pascale Plas France	14	207 0.8×	163 0.9×	198 1.2×	101 1.4×	31 0.4×	24	623
Noriyuki Naya Japan	14	230 0.9×	71 0.4×	155 0.9×	41 0.6×	99 1.4×	30	521
Jun‐ichi Imagawa Japan	12	158 0.6×	151 0.8×	124 0.7×	18 0.3×	62 0.9×	35	625
Marilyn Grous United States	12	433 1.6×	264 1.5×	37 0.2×	95 1.3×	56 0.8×	22	681
Lindsay S. Wilson Canada	10	415 1.5×	105 0.6×	164 1.0×	18 0.3×	41 0.6×	11	529
Preeti Singh United States	13	232 0.9×	113 0.6×	119 0.7×	66 0.9×	22 0.3×	33	556
Irina G. Rybalkina United States	6	401 1.5×	183 1.0×	154 0.9×	48 0.7×	34 0.5×	8	521
Georgina M. Nemecek United States	9	184 0.7×	60 0.3×	76 0.4×	36 0.5×	18 0.3×	12	398

Countries citing papers authored by L T Hamel

Since Specialization

Citations

This map shows the geographic impact of L T Hamel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L T Hamel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L T Hamel more than expected).

Fields of papers citing papers by L T Hamel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L T Hamel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L T Hamel. The network helps show where L T Hamel may publish in the future.

Co-authorship network of co-authors of L T Hamel

This figure shows the co-authorship network connecting the top 25 collaborators of L T Hamel. A scholar is included among the top collaborators of L T Hamel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L T Hamel. L T Hamel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

1.

Hamel, L T, Zaid Jayyosi, Ali Ardati, et al.. (2000). Induction of heat shock protein 70 by herbimycin A and cyclopentenone prostaglandins in smooth muscle cells. Cell Stress and Chaperones. 5(2). 121–121. 13 indexed citations

2.

Roemeling, Reinhard von, et al.. (2000). Comparison of Urinary Desmosine Excretion in Patients with Chronic Obstructive Pulmonary Disease or Cystic Fibrosis. Pulmonary Pharmacology & Therapeutics. 13(4). 175–180. 36 indexed citations

3.

Hamel, L T, et al.. (2000). Preconditioning of Human Smooth Muscle Cells via Cyclopentenone Prostaglandins Protects against Toxic Effects of Oxidized Low-Density Lipoprotein. Biochemical and Biophysical Research Communications. 269(2). 327–330. 7 indexed citations

4.

Singh, Baldev, Edward R. Bacon, George Y. Lesher, et al.. (1995). Novel and Potent Adenosine 3',5'-Cyclic Phosphate Phosphodiesterase III Inhibitors: Thiazolo[4,5-b][1,6]naphthyridin-2-ones. Journal of Medicinal Chemistry. 38(14). 2546–2550. 24 indexed citations

5.

Silver, Paul J., Ronald L. Dundore, Lawrence de Garavilla, et al.. (1994). Cyclic GMP potentiation by WIN 58237, a novel cyclic nucleotide phosphodiesterase inhibitor.. Journal of Pharmacology and Experimental Therapeutics. 271(3). 1143–1149. 20 indexed citations

6.

Hamel, L T, et al.. (1993). Distinct profiles of phosphodiesterase isozymes in cultured cells derived from nonpigmented and pigmented ocular ciliary epithelium.. Journal of Pharmacology and Experimental Therapeutics. 267(3). 1286–1291. 6 indexed citations

7.

Singh, Baldev, George Y. Lesher, Edward D. Pagani, et al.. (1992). Novel cAMP PDE III inhibitors: 1,6-naphthyridin-2(1H)-ones. Journal of Medicinal Chemistry. 35(26). 4858–4865. 13 indexed citations

8.

Silver, Paul J., et al.. (1991). Inhibition of low Km cGMP phosphodiesterases and Ca+(+)-regulated protein kinases and relationship to vasorelaxation by cicletanine.. Journal of Pharmacology and Experimental Therapeutics. 257(1). 382–391. 22 indexed citations

9.

Perrone, Mark H., et al.. (1990). Napamezole, an alpha-2 adrenergic receptor antagonist and monoamine uptake inhibitor in vitro.. Journal of Pharmacology and Experimental Therapeutics. 254(2). 471–475. 7 indexed citations

10.

Perrone, Mark H., et al.. (1990). In vivo assessment of napamezole, an alpha-2 adrenoceptor antagonist and monoamine re-uptake inhibitor.. Journal of Pharmacology and Experimental Therapeutics. 254(2). 476–483. 13 indexed citations

11.

Silver, Paul J., L T Hamel, Ross Bentley, et al.. (1990). Inhibition of cardiovascular low‐K_m cAMP phosphodiesterase activity by medorinone. Drug Development Research. 21(2). 93–104. 5 indexed citations

12.

Silver, Paul J., et al.. (1990). Cellular distribution and pharmacological sensitivity of low Km cyclic nucleotide phosphodiesterase isozymes in human cardiac muscle from normal and cardiomyopathic subjects.. PubMed. 13(1). 13–25. 17 indexed citations

13.

Harris, Alex L., et al.. (1989). Phosphodiesterase isozyme inhibition and the potentiation by zaprinast of endothelium-derived relaxing factor and guanylate cyclase stimulating agents in vascular smooth muscle.. Journal of Pharmacology and Experimental Therapeutics. 249(2). 394–400. 48 indexed citations

14.

Silver, Paul J., Alex L. Harris, Paul C. Canniff, et al.. (1989). Phosphodiesterase Isozyme Inhibition, Activation of the cAMP System, and Positive Inotropy Mediated by Milrinone in Isolated Guinea Pig Cardiac Muscle. Journal of Cardiovascular Pharmacology. 13(4). 530–540. 48 indexed citations

15.

Silver, Paul J., Alex L. Harris, Paul C. Canniff, et al.. (1989). Phosphodiesterase Isozyme Inhibition, Activation of the cAMP System, and Positive Inotropy Mediated by Milrinone in Isolated Guinea Pig Cardiac Muscle. Journal of Cardiovascular Pharmacology. 13(4). 530–540. 51 indexed citations

16.

Silver, Paul J., et al.. (1988). Inhibition of the low Km cyclic AMP phosphodiesterase and activation of the cyclic AMP system in vascular smooth muscle by milrinone.. Journal of Pharmacology and Experimental Therapeutics. 247(1). 34–42. 66 indexed citations

17.

Silver, Paul J., et al.. (1988). Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac muscle, arterial and airway smooth muscle. European Journal of Pharmacology. 150(1-2). 85–94. 97 indexed citations

18.

Luttinger, Daniel, et al.. (1984). The effects of serotonin antagonists in a behavioral despair procedure in mice. European Journal of Pharmacology. 107(1). 53–58. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact